Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hope therapy boosts recovery in seniors after hip fracture surgery

NCT ID NCT07400770

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 19, 2026 · Updated 2 times

Summary

This study tests a special nursing program based on Snyder Hope Theory for people aged 60 and older who recently had hip fracture surgery. The program includes counseling, goal setting, and rehab training to improve hope, reduce pain and anxiety, and help patients regain function. Around 112 participants will be randomly assigned to receive either this hope-based care or standard care, and researchers will track changes in mood, pain, and recovery over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

112 people

The number who actually took part.

Started

May 2024

Finished

Dec 2025

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 60 years. * Patients with hip fracture requiring surgical intervention. * Patients who have undergone hip fracture surgery within the past 2 weeks. * Patients who are able to communicate and provide informed consent. * Patients and/or their family members who are willing to participate in the study. Exclusion Criteria: * Patients with other lower limb fractures or history of lower limb thrombosis. * Patients with multiple fractures. * Patients with severe damage to major organs (heart, lungs, brain) or malignant tumors. * Patients who have undergone hip replacement surgery in the past. * Patients with infectious diseases or immune system disorders. * Patients with chronic diseases or neurological disorders.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Elderly patients are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Taizhou No. 3 People's Hospital

    Taizhou, Jiangsu, 225300, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.